Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours.
about
Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice.Regression of liver metastases of occult carcinoid tumor with slow release lanreotide therapy.Primary hepatic carcinoid: a case report and literature review.The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.
P2860
Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Use of octreotide and lanreoti ...... -resectable carcinoid tumours.
@en
Use of octreotide and lanreoti ...... -resectable carcinoid tumours.
@nl
type
label
Use of octreotide and lanreoti ...... -resectable carcinoid tumours.
@en
Use of octreotide and lanreoti ...... -resectable carcinoid tumours.
@nl
prefLabel
Use of octreotide and lanreoti ...... -resectable carcinoid tumours.
@en
Use of octreotide and lanreoti ...... -resectable carcinoid tumours.
@nl
P2860
P1476
Use of octreotide and lanreoti ...... -resectable carcinoid tumours.
@en
P2093
John Richard Farndon
Muhammad Rohaizak
P2860
P304
P356
10.1046/J.1445-2197.2002.02507.X
P577
2002-09-01T00:00:00Z